Immatics (IMTX) EBITDA Margin (2019 - 2026)
Immatics' EBITDA Margin was -702.12% in Q2 2026, up 355.53 percentage points from -1057.65% a year earlier and up 129.32 percentage points from the prior quarter.
Powered by 
Analysis
Immatics (IMTX) EBITDA Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immatics' EBITDA Margin was -515.52% through Jun 30, 2026, down 456.84 percentage points year-over-year; for FY2025, it was -351.42%, down 334.48 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -142.51 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -16.93% in FY2024 (+158.06 pp), -174.99% in FY2023 (-196.36 pp), 21.36% in FY2022 (+254.47 pp) and -233.10% in FY2021 (-24.19 pp).
- Quarterly EBITDA Margin has moved between -1057.65% (Q2 2025) and 68.15% (Q1 2022) over five years.
- Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of -231.81 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2024 (a gain of 538.59 percentage points); the worst was Q3 2025 (a drop of 1001.19 percentage points).
- Per Business Quant data, IMTX's EBITDA Margin in the three quarters before Q2 2026 was -831.44% (Q1 2026), -180.72% (Q4 2025) and -994.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Immatics | 1.14 Bn | -898.62 Mn | - | -702.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -702.12% |
| Mar 31, 2026 | -831.44% |
| Dec 31, 2025 | -180.72% |
| Sep 30, 2025 | -994.18% |
| Jun 30, 2025 | -1,057.65% |
| Mar 31, 2025 | -173.47% |
| Dec 31, 2024 | 7.07% |
| Sep 30, 2024 | 7.02% |
| Jun 30, 2024 | -125.10% |
| Mar 31, 2024 | -34.54% |
| Dec 31, 2023 | -162.75% |
| Sep 30, 2023 | -531.57% |
| Jun 30, 2023 | -55.74% |
| Mar 31, 2023 | -251.32% |
| Dec 31, 2022 | 4.77% |
| Sep 30, 2022 | -133.56% |
| Jun 30, 2022 | -86.47% |
| Mar 31, 2022 | 68.15% |
| Dec 31, 2021 | -93.90% |
| Sep 30, 2021 | -330.56% |
API Access
Immatics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();